trial · primary record
Wafermine™ (ketamine sublingual wafer)
Healthy Adult Participants
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2026-08-12 |
| Primary endpoint | Peak Plasma Concentration (Cmax) of Ketamine and Norketamine |
| Registry ID | NCT07691372 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:49.143Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07691372
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.